88 related articles for article (PubMed ID: 12531009)
1. A:T --> G:C base pair substitutions occur at a higher rate than other substitution events in Pms2 deficient mouse cells.
Shin CY; Turker MS
DNA Repair (Amst); 2002 Dec; 1(12):995-1001. PubMed ID: 12531009
[TBL] [Abstract][Full Text] [Related]
2. Multiple mutations are common at mouse Aprt in genotoxin-exposed mismatch repair deficient cells.
Shin CY; Mellon I; Turker MS
Oncogene; 2002 Mar; 21(11):1768-76. PubMed ID: 11896608
[TBL] [Abstract][Full Text] [Related]
3. A role for Pms2 in the prevention of tandem CC --> TT substitutions induced by ultraviolet radiation and oxidative stress.
Shin-Darlak CY; Skinner AM; Turker MS
DNA Repair (Amst); 2005 Jan; 4(1):51-7. PubMed ID: 15533837
[TBL] [Abstract][Full Text] [Related]
4. Contributions by MutL homologues Mlh3 and Pms2 to DNA mismatch repair and tumor suppression in the mouse.
Chen PC; Dudley S; Hagen W; Dizon D; Paxton L; Reichow D; Yoon SR; Yang K; Arnheim N; Liskay RM; Lipkin SM
Cancer Res; 2005 Oct; 65(19):8662-70. PubMed ID: 16204034
[TBL] [Abstract][Full Text] [Related]
5. Frequency and types of spontaneous Hprt lymphocyte mutations in Pms2-deficient mice.
Shaddock JG; Dobrovolsky VN; Mittelstaedt RA; Heflich RH; Parsons BL
Mutat Res; 2006 Mar; 595(1-2):69-79. PubMed ID: 16336979
[TBL] [Abstract][Full Text] [Related]
6. Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination.
Ehrenstein MR; Rada C; Jones AM; Milstein C; Neuberger MS
Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14553-8. PubMed ID: 11717399
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and point mutation at Aprt locus in T cells and fibroblasts of Pms2-/- mice.
Shao C; Yin M; Deng L; Stambrook PJ; Doetschman T; Tischfield JA
Oncogene; 2002 Apr; 21(18):2840-5. PubMed ID: 11973643
[TBL] [Abstract][Full Text] [Related]
8. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions.
Schrader CE; Vardo J; Stavnezer J
J Exp Med; 2002 Feb; 195(3):367-73. PubMed ID: 11828012
[TBL] [Abstract][Full Text] [Related]
9. Mismatch repair gene PMS2: disease-causing germline mutations are frequent in patients whose tumors stain negative for PMS2 protein, but paralogous genes obscure mutation detection and interpretation.
Nakagawa H; Lockman JC; Frankel WL; Hampel H; Steenblock K; Burgart LJ; Thibodeau SN; de la Chapelle A
Cancer Res; 2004 Jul; 64(14):4721-7. PubMed ID: 15256438
[TBL] [Abstract][Full Text] [Related]
10. Truncation of the C-terminus of human MLH1 blocks intracellular stabilization of PMS2 and disrupts DNA mismatch repair.
Mohd AB; Palama B; Nelson SE; Tomer G; Nguyen M; Huo X; Buermeyer AB
DNA Repair (Amst); 2006 Mar; 5(3):347-61. PubMed ID: 16338176
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the lack of mismatch-repair directed antirecombination during mouse meiosis.
Qin J; Baker S; Te Riele H; Liskay RM; Arnheim N
J Hered; 2002; 93(3):201-5. PubMed ID: 12195036
[TBL] [Abstract][Full Text] [Related]
12. Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea.
Qin X; Shibata D; Gerson SL
Carcinogenesis; 2000 Apr; 21(4):833-8. PubMed ID: 10753224
[TBL] [Abstract][Full Text] [Related]
13. Mutagenesis in PMS2- and MSH2-deficient mice indicates differential protection from transversions and frameshifts.
Andrew SE; Xu XS; Baross-Francis A; Narayanan L; Milhausen K; Liskay RM; Jirik FR; Glazer PM
Carcinogenesis; 2000 Jul; 21(7):1291-5. PubMed ID: 10874005
[TBL] [Abstract][Full Text] [Related]
14. Pms2 is a genetic enhancer of trinucleotide CAG.CTG repeat somatic mosaicism: implications for the mechanism of triplet repeat expansion.
Gomes-Pereira M; Fortune MT; Ingram L; McAbney JP; Monckton DG
Hum Mol Genet; 2004 Aug; 13(16):1815-25. PubMed ID: 15198993
[TBL] [Abstract][Full Text] [Related]
15. Phenotype associated with recessively inherited mutations in DNA mismatch repair (MMR) genes.
de Vos M; Hayward B; Bonthron DT; Sheridan E
Biochem Soc Trans; 2005 Aug; 33(Pt 4):718-20. PubMed ID: 16042583
[TBL] [Abstract][Full Text] [Related]
16. Visualization of mosaicism in tissues of normal and mismatch-repair-deficient mice carrying a microsatellite-containing transgene.
Hersh MN; Stambrook PJ; Stringer JR
Mutat Res; 2002 Aug; 505(1-2):51-62. PubMed ID: 12175905
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of p53-deficient cells to anticancer agents due to loss of Pms2.
Fedier A; Ruefenacht UB; Schwarz VA; Haller U; Fink D
Br J Cancer; 2002 Oct; 87(9):1027-33. PubMed ID: 12434296
[TBL] [Abstract][Full Text] [Related]
18. Alterations in PMS2, MSH2 and MLH1 expression in human prostate cancer.
Chen Y; Wang J; Fraig MM; Henderson K; Bissada NK; Watson DK; Schweinfest CW
Int J Oncol; 2003 May; 22(5):1033-43. PubMed ID: 12684669
[TBL] [Abstract][Full Text] [Related]
19. Elevated mutant frequencies and increased C : G-->T : A transitions in Mlh1-/- versus Pms2-/- murine small intestinal epithelial cells.
Baross-Francis A; Makhani N; Liskay RM; Jirik FR
Oncogene; 2001 Feb; 20(5):619-25. PubMed ID: 11313994
[TBL] [Abstract][Full Text] [Related]
20. Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: case series, review and follow-up guidelines.
Herkert JC; Niessen RC; Olderode-Berends MJ; Veenstra-Knol HE; Vos YJ; van der Klift HM; Scheenstra R; Tops CM; Karrenbeld A; Peters FT; Hofstra RM; Kleibeuker JH; Sijmons RH
Eur J Cancer; 2011 May; 47(7):965-82. PubMed ID: 21376568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
